A consortium just bought 25 Healthscope hospitals, and it says a lot about who actually owns Australian healthcare now

A consortium just carved up what is left of Healthscope, and the shakeup says a lot about who actually owns Australia's private hospitals now.

A consortium led by Catholic not for profit group Calvary Health Care has been approved to take over the 25 Healthscope hospitals it did not already own, joined by Healthe Care, Acurio Health and KnG. Calvary will run 14 of the 25 hospitals, having already picked up two others last year when Healthscope first collapsed. Healthe Care, owned by private equity group Pacific Equity Partners, takes six hospitals including Prince of Wales Private in Sydney and Knox Private in Melbourne's east. Acurio Health, focused around Sydney's west, picks up three, and KnG takes two smaller Queensland facilities.

The deal follows Healthscope's slow collapse under 1.6 billion dollars in debt, after its North American private equity owner Brookfield withdrew support and the company went into receivership last year. The proposal still needs definitive transaction documents and the usual state and territory regulatory approvals for transferring hospital licences, so it is not finalised yet.

What is worth sitting with here is the mix of buyers. A not for profit religious health provider picking up the largest single share, alongside multiple private equity backed operators, means Australia's private hospital system is ending up more fragmented and more mixed in ownership model than it was a year ago. Most patients will only notice when their local hospital's signage changes, if they notice at all, but who owns the beds shapes decisions about services, staffing and pricing long after any sale actually closes.

Healthscope was Australia's second largest private hospital operator before its collapse, so a split of this scale is not a minor correction to the sector, it is a genuine restructuring of who controls private healthcare capacity across several states at once.

Worth keeping an eye on the regulatory approvals process from here, since a deal this size affects genuinely essential infrastructure, not just a line in a corporate ledger.